Abstract
Components of metabolic syndrome, including elevated serum insulin and C-peptide levels, seem to affect risk of developing prostate cancer, but inconsistently. Recently, an inverse association was reported in a prospective U.S. study ([1][1]), whereas a prospective Norwegian study reported the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
